Position in CRNX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$20,771,370
-$21,504,966 QoQ
Shares Held
571,899
-37.0% QoQ
Ownership
0.542%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 98.94369460341773.ToString("F0")%
Shared 0.ToString("F0")%
None 1.0563053965822637.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Derivatives in CRNX
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$936,200
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. CRNX ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in CRNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,771,370 | 571,899 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $42,276,336 | 908,192 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $16,981,619 | 407,722 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,218,873 | 320,545 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,587,201 | 315,659 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $36,186,233 | 707,730 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,345,474 | 182,886 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,193,971 | 182,942 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $936,200 | 20,000 | Put | Defined | 2024-05-13 | |
| 2024-03-31 | $11,599,658 | 247,803 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,926,584 | 138,465 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,434,456 | 81,858 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,625,387 | 145,693 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $950,238 | 59,168 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,476,700 | 80,694 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $159,849 | 8,139 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $357,707 | 19,180 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,503,421 | 68,493 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,500,615 | 52,820 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $446,828 | 21,227 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $63,091 | 4,129 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $29,616 | 2,099 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $159,309 | 9,093 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $120,775 | 8,216 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||